Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes.

To identify molecular alterations in prostate cancers associating with relapse following neoadjuvant chemotherapy and radical prostatectomy patients with high-risk localized prostate cancer were enrolled into a phase I-II clinical trial of neoadjuvant chemotherapy with docetaxel and mitoxantrone fol...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Ryan R Gordon, Mengchu Wu, Chung-Ying Huang, William P Harris, Hong Gee Sim, Jared M Lucas, Ilsa Coleman, Celestia S Higano, Roman Gulati, Lawrence D True, Robert Vessella, Paul H Lange, Mark Garzotto, Tomasz M Beer, Peter S Nelson
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Public Library of Science (PLoS) 2014-01-01
Serie:	PLoS ONE
Accesso online:	http://europepmc.org/articles/PMC4157741?pdf=render
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!